Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2005 6
2006 2
2007 1
2008 3
2009 4
2010 2
2011 5
2012 7
2013 3
2014 2
2015 8
2016 10
2017 4
2018 3
2019 8
2020 9
2021 8
2022 9
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of COPD.
Raherison C, Girodet PO. Raherison C, et al. Among authors: girodet po. Eur Respir Rev. 2009 Dec;18(114):213-21. doi: 10.1183/09059180.00003609. Eur Respir Rev. 2009. PMID: 20956146 Free article. Review.
Reply.
Vandenborght LE, Enaud R, Urien C, Coron N, Girodet PO, Ferreira S, Berger P, Delhaes L. Vandenborght LE, et al. Among authors: girodet po. J Allergy Clin Immunol. 2021 Feb;147(2):779-780. doi: 10.1016/j.jaci.2020.10.021. Epub 2020 Dec 1. J Allergy Clin Immunol. 2021. PMID: 33276993 No abstract available.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Jackson DJ, Heaney LG, Humbert M, Kent BD, Shavit A, Hiljemark L, Olinger L, Cohen D, Menzies-Gow A, Korn S; SHAMAL Investigators. Jackson DJ, et al. Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7. Lancet. 2024. PMID: 38071986 Free article. Clinical Trial.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Reply.
Dupin I, Girodet PO, Berger P. Dupin I, et al. Among authors: girodet po. J Allergy Clin Immunol. 2016 May;137(5):1626. doi: 10.1016/j.jaci.2016.01.022. Epub 2016 Mar 22. J Allergy Clin Immunol. 2016. PMID: 27012640 No abstract available.
Clinical pharmacology: Current innovations and future challenges.
Cracowski JL, Hulot JS, Laporte S, Charvériat M, Roustit M, Deplanque D, Girodet PO; French Society of Pharmacology and Therapeutics (SFPT). Cracowski JL, et al. Among authors: girodet po. Fundam Clin Pharmacol. 2022 Jun;36(3):456-467. doi: 10.1111/fcp.12747. Epub 2022 Jan 26. Fundam Clin Pharmacol. 2022. PMID: 34954839 Review.
[Asthma exacerbations: pharmacological prevention].
Grassin-Delyle S, Girodet PO. Grassin-Delyle S, et al. Among authors: girodet po. Rev Mal Respir. 2012 Feb;29(2):232-44. doi: 10.1016/j.rmr.2011.05.018. Epub 2012 Jan 9. Rev Mal Respir. 2012. PMID: 22405116 Review. French.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
92 results